Stifel Financial Corp reduced its holdings in Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 69.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 20,275 shares of the company's stock after selling 46,195 shares during the quarter. Stifel Financial Corp owned about 0.05% of Crescent Capital BDC worth $390,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Montag A & Associates Inc. bought a new position in shares of Crescent Capital BDC in the fourth quarter valued at approximately $35,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Crescent Capital BDC during the fourth quarter worth $39,000. Generation Capital Management LLC acquired a new stake in shares of Crescent Capital BDC in the fourth quarter valued at $192,000. Dynamic Technology Lab Private Ltd bought a new stake in Crescent Capital BDC during the 4th quarter worth about $218,000. Finally, NewEdge Advisors LLC grew its holdings in Crescent Capital BDC by 4,308.4% during the 4th quarter. NewEdge Advisors LLC now owns 12,079 shares of the company's stock worth $232,000 after acquiring an additional 11,805 shares during the last quarter. 49.46% of the stock is owned by institutional investors and hedge funds.
Crescent Capital BDC Price Performance
NASDAQ CCAP traded down $0.52 during midday trading on Friday, hitting $15.42. The company had a trading volume of 416,784 shares, compared to its average volume of 135,676. The company has a market capitalization of $571.47 million, a PE ratio of 7.75 and a beta of 0.63. Crescent Capital BDC, Inc. has a twelve month low of $13.54 and a twelve month high of $20.19. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. The firm has a 50-day moving average price of $16.22 and a 200-day moving average price of $18.09.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its quarterly earnings data on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.52 by ($0.07). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The firm had revenue of $42.13 million during the quarter, compared to the consensus estimate of $45.08 million. As a group, analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.
Crescent Capital BDC Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Monday, June 30th will be issued a $0.42 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 10.89%. Crescent Capital BDC's dividend payout ratio is presently 84.42%.
Analyst Ratings Changes
A number of brokerages have recently issued reports on CCAP. Keefe, Bruyette & Woods lowered shares of Crescent Capital BDC from an "outperform" rating to a "market perform" rating and reduced their target price for the stock from $18.50 to $17.00 in a research report on Friday. Raymond James reduced their price objective on Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating for the company in a research report on Friday. Finally, Wells Fargo & Company decreased their target price on shares of Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $17.60.
Check Out Our Latest Research Report on Crescent Capital BDC
About Crescent Capital BDC
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Read More
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
